Re: Resverlogix Clinical Candidate Apabetalone Featured as a Potential COVID-19 Treatment in Recent Publication
posted on
Mar 26, 2020 06:41PM
"Bear you seem to take the NKF cal as of little importance,or am I getting a wrong impression?"
You have the wrong impression. I am frustrated about how long it has taken for Resverlogix to reveal the results of the CKD sub-study. However, I am still hopeful that it holds exciting data for kidney function beyond just the already disclosed MACE data. The data itself is more important to me than the timing/venue.
BDAZ